TY - STD TI - EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–43. ID - ref1 ER - TY - JOUR AU - Llovet, J. M. AU - Ricci, S. AU - Mazzaferro, V. AU - Hilgard, P. AU - Gane, E. AU - Blanc, J. F. PY - 2008 DA - 2008// TI - Sorafenib in advanced hepatocellular carcinoma JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0708857 DO - 10.1056/NEJMoa0708857 ID - Llovet2008 ER - TY - JOUR AU - Kudo, M. AU - Finn, R. S. AU - Qin, S. AU - Han, K. H. AU - Ikeda, K. AU - Piscaglia, F. PY - 2018 DA - 2018// TI - Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial JO - Lancet. VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)30207-1 DO - 10.1016/S0140-6736(18)30207-1 ID - Kudo2018 ER - TY - JOUR AU - Bruix, J. AU - Raoul, J. L. AU - Sherman, M. AU - Mazzaferro, V. AU - Bolondi, L. AU - Craxi, A. PY - 2012 DA - 2012// TI - Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial JO - J Hepatol VL - 57 UR - https://doi.org/10.1016/j.jhep.2012.06.014 DO - 10.1016/j.jhep.2012.06.014 ID - Bruix2012 ER - TY - JOUR AU - Yoon, S. M. AU - Ryoo, B. Y. AU - Lee, S. J. AU - Kim, J. H. AU - Shin, J. H. AU - An, J. H. PY - 2018 DA - 2018// TI - Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: a randomized clinical trial JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2017.5847 DO - 10.1001/jamaoncol.2017.5847 ID - Yoon2018 ER - TY - JOUR AU - Kasuya, G. AU - Kato, H. AU - Yasuda, S. AU - Tsuji, H. AU - Yamada, S. AU - Haruyama, Y. PY - 2017 DA - 2017// TI - Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: combined analyses of 2 prospective trials JO - Cancer. VL - 123 UR - https://doi.org/10.1002/cncr.30816 DO - 10.1002/cncr.30816 ID - Kasuya2017 ER - TY - JOUR AU - Shiba, S. AU - Abe, T. AU - Shibuya, K. AU - Katoh, H. AU - Koyama, Y. AU - Shimada, H. PY - 2017 DA - 2017// TI - Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma JO - BMC Cancer VL - 17 UR - https://doi.org/10.1186/s12885-017-3724-4 DO - 10.1186/s12885-017-3724-4 ID - Shiba2017 ER - TY - JOUR AU - Shibuya, K. AU - Ohno, T. AU - Katoh, H. AU - Okamoto, M. AU - Shiba, S. AU - Koyama, Y. PY - 2019 DA - 2019// TI - A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3cm or larger JO - Radiother Oncol VL - 132 UR - https://doi.org/10.1016/j.radonc.2018.10.009 DO - 10.1016/j.radonc.2018.10.009 ID - Shibuya2019 ER - TY - JOUR AU - Shibuya, K. AU - Ohno, T. AU - Terashima, K. AU - Toyama, S. AU - Yasuda, S. AU - Tsuji, H. PY - 2018 DA - 2018// TI - Short-course carbon-ion radiotherapy for hepatocellular carcinoma: a multi-institutional retrospective study JO - Liver Int VL - 38 UR - https://doi.org/10.1111/liv.13969 DO - 10.1111/liv.13969 ID - Shibuya2018 ER - TY - JOUR AU - Shiba, S. AU - Shibuya, K. AU - Kawashima, M. AU - Okano, N. AU - Kaminuma, T. AU - Okamoto, M. PY - 2020 DA - 2020// TI - Evaluation of advantages in dose-distribution with carbon ion radiotherapy versus intensity-modulated radiation therapy for hepatocellular carcinoma with macroscopic vascular invasion JO - Anticancer Res VL - 40 UR - https://doi.org/10.21873/anticanres.13974 DO - 10.21873/anticanres.13974 ID - Shiba2020 ER - TY - JOUR AU - Abe, T. AU - Saitoh, J. AU - Kobayashi, D. AU - Shibuya, K. AU - Koyama, Y. AU - Shimada, H. PY - 2015 DA - 2015// TI - Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma JO - Radiat Oncol VL - 10 UR - https://doi.org/10.1186/s13014-015-0491-8 DO - 10.1186/s13014-015-0491-8 ID - Abe2015 ER - TY - STD TI - Tsujii H, Kamada T, Shirai T, et al. Carbon-Ion Radiotherapy: Springer; 2014. ID - ref12 ER - TY - JOUR AU - Nakano, T. AU - Suzuki, Y. AU - Ohno, T. AU - Kato, S. AU - Suzuki, M. AU - Morita, S. PY - 2006 DA - 2006// TI - Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-1907 DO - 10.1158/1078-0432.CCR-05-1907 ID - Nakano2006 ER - TY - JOUR AU - Cui, X. AU - Oonishi, K. AU - Tsujii, H. AU - Yasuda, T. AU - Matsumoto, Y. AU - Furusawa, Y. PY - 2011 DA - 2011// TI - Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-2926 DO - 10.1158/0008-5472.CAN-10-2926 ID - Cui2011 ER - TY - JOUR AU - Kudo, M. AU - Izumi, N. AU - Kubo, S. AU - Kokudo, N. AU - Sakamoto, M. AU - Shiina, S. PY - 2020 DA - 2020// TI - Report of the 20th Nationwide follow-up survey of primary liver Cancer in Japan JO - Hepatol Res VL - 50 UR - https://doi.org/10.1111/hepr.13438 DO - 10.1111/hepr.13438 ID - Kudo2020 ER - TY - JOUR AU - Llovet, J. M. AU - Bru, C. AU - Bruix, J. PY - 1999 DA - 1999// TI - Prognosis of hepatocellular carcinoma: the BCLC staging classification JO - Semin Liver Dis VL - 19 UR - https://doi.org/10.1055/s-2007-1007122 DO - 10.1055/s-2007-1007122 ID - Llovet1999 ER - TY - JOUR AU - Johnson, P. J. AU - Berhane, S. AU - Kagebayashi, C. AU - Satomura, S. AU - Teng, M. AU - Reeves, H. L. PY - 2015 DA - 2015// TI - Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.57.9151 DO - 10.1200/JCO.2014.57.9151 ID - Johnson2015 ER - TY - JOUR AU - Kanematsu, N. PY - 2011 DA - 2011// TI - Dose calculation algorithm of fast fine-heterogeneity correction for heavy charged particle radiotherapy JO - Phys Med VL - 27 UR - https://doi.org/10.1016/j.ejmp.2010.05.001 DO - 10.1016/j.ejmp.2010.05.001 ID - Kanematsu2011 ER - TY - JOUR AU - Inaniwa, T. AU - Kanematsu, N. AU - Matsufuji, N. AU - Kanai, T. AU - Shirai, T. AU - Noda, K. PY - 2015 DA - 2015// TI - Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan JO - Phys Med Biol VL - 60 UR - https://doi.org/10.1088/0031-9155/60/8/3271 DO - 10.1088/0031-9155/60/8/3271 ID - Inaniwa2015 ER - TY - JOUR AU - Tashiro, T. AU - Ishii, T. AU - Koya, J. AU - Okada, R. AU - Kurosawa, Y. AU - Arai, K. PY - 2013 DA - 2013// TI - Technical approach to individualized respiratory-gated carbon-ion therapy for mobile organs JO - Radiol Phys Technol VL - 6 UR - https://doi.org/10.1007/s12194-013-0208-3 DO - 10.1007/s12194-013-0208-3 ID - Tashiro2013 ER - TY - JOUR AU - Kubota, Y. AU - Tashiro, M. AU - Shinohara, A. AU - Abe, S. AU - Souda, S. AU - Okada, R. PY - 2015 DA - 2015// TI - Development of an automatic evaluation method for patient positioning error JO - J Appl Clin Med Phys VL - 16 UR - https://doi.org/10.1120/jacmp.v16i4.5400 DO - 10.1120/jacmp.v16i4.5400 ID - Kubota2015 ER - TY - JOUR AU - Abe, S. AU - Kubota, Y. AU - Shibuya, K. AU - Koyama, Y. AU - Abe, T. AU - Ohno, T. PY - 2017 DA - 2017// TI - Fiducial marker matching versus vertebral body matching. Dosimetric impact of patient positioning in carbon ion radiotherapy for primary hepatic cancer JO - Phys Med VL - 33 UR - https://doi.org/10.1016/j.ejmp.2016.12.018 DO - 10.1016/j.ejmp.2016.12.018 ID - Abe2017 ER - TY - JOUR AU - Kubota, Y. AU - Katoh, H. AU - Shibuya, K. AU - Shiba, S. AU - Abe, S. AU - Sakai, M. PY - 2019 DA - 2019// TI - Comparison between bone matching and marker matching for evaluation of intra- and inter-fractional changes in accumulated of carbon ion radiotherapy for hepatocellular carcinoma JO - Radiother Oncol VL - 137 UR - https://doi.org/10.1016/j.radonc.2019.04.026 DO - 10.1016/j.radonc.2019.04.026 ID - Kubota2019 ER - TY - STD TI - US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. In: National Institutes of Health: National Cancer Institute; 2009. ID - ref24 ER - TY - JOUR AU - Kodama, K. AU - Kawaoka, T. AU - Aikata, H. AU - Uchikawa, S. AU - Nishida, Y. AU - Inagaki, Y. PY - 2018 DA - 2018// TI - Comparison of outcome of hepatic arterial infusion chemotherapy combined with radiotherapy and sorafenib for advanced hepatocellular carcinoma patients with major portal vein tumor thrombosis JO - Oncology. VL - 94 UR - https://doi.org/10.1159/000486483 DO - 10.1159/000486483 ID - Kodama2018 ER - TY - JOUR AU - Zhang, X. AU - Wang, K. AU - Wang, M. AU - Yang, G. AU - Ye, X. F. AU - Wu, M. C. PY - 2017 DA - 2017// TI - Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.15075 DO - 10.18632/oncotarget.15075 ID - Zhang2017 ER - TY - JOUR AU - Liu, P. H. AU - Lee, Y. H. AU - Hsia, C. Y. AU - Hsu, C. Y. AU - Huang, Y. H. AU - Chiou, Y. Y. PY - 2014 DA - 2014// TI - Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis JO - Ann Surg Oncol VL - 21 UR - https://doi.org/10.1245/s10434-014-3510-3 DO - 10.1245/s10434-014-3510-3 ID - Liu2014 ER - TY - JOUR AU - Shi, J. AU - Lai, E. C. AU - Li, N. AU - Guo, W. X. AU - Xue, J. AU - Lau, W. Y. PY - 2010 DA - 2010// TI - Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus JO - Ann Surg Oncol VL - 17 UR - https://doi.org/10.1245/s10434-010-0940-4 DO - 10.1245/s10434-010-0940-4 ID - Shi2010 ER - TY - JOUR AU - Komatsu, S. AU - Kido, M. AU - Asari, S. AU - Toyama, H. AU - Ajiki, T. AU - Demizu, Y. PY - 2017 DA - 2017// TI - Particle radiotherapy, a novel external radiation therapy, versus liver resection for hepatocellular carcinoma accompanied with inferior vena cava tumor thrombus: a matched-pair analysis JO - Surgery. VL - 162 UR - https://doi.org/10.1016/j.surg.2017.08.006 DO - 10.1016/j.surg.2017.08.006 ID - Komatsu2017 ER - TY - JOUR AU - Liang, S. X. AU - Zhu, X. D. AU - Xu, Z. Y. AU - Zhu, J. AU - Zhao, J. D. AU - Lu, H. J. PY - 2006 DA - 2006// TI - Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance JO - Int J Radiat Oncol Biol Phys VL - 65 UR - https://doi.org/10.1016/j.ijrobp.2005.12.031 DO - 10.1016/j.ijrobp.2005.12.031 ID - Liang2006 ER - TY - JOUR AU - Komatsu, S. AU - Fukumoto, T. AU - Demizu, Y. AU - Miyawaki, D. AU - Terashima, K. AU - Niwa, Y. PY - 2011 DA - 2011// TI - The effectiveness of particle radiotherapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus JO - J Gastroenterol VL - 46 UR - https://doi.org/10.1007/s00535-011-0398-6 DO - 10.1007/s00535-011-0398-6 ID - Komatsu2011 ER -